RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Xioxin Chen to Antineoplastic Agents

This is a "connection" page, showing publications Xioxin Chen has written about Antineoplastic Agents.
Connection Strength

0.237
  1. Liu Y, Xiong Z, Beasley A, D'Amico T, Chen XL. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update. Ann N Y Acad Sci. 2016 10; 1381(1):66-73.
    View in: PubMed
    Score: 0.082
  2. Zhu Y, Fu J, Shurlknight KL, Soroka DN, Hu Y, Chen X, Sang S. Novel Resveratrol-Based Aspirin Prodrugs: Synthesis, Metabolism, and Anticancer Activity. J Med Chem. 2015 Aug 27; 58(16):6494-506.
    View in: PubMed
    Score: 0.077
  3. Zhang X, Yang F, Shim JY, Kirk KL, Anderson DE, Chen X. Identification of arsenic-binding proteins in human breast cancer cells. Cancer Lett. 2007 Sep 18; 255(1):95-106.
    View in: PubMed
    Score: 0.043
  4. Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, Lee MJ, Yang CS. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis. 2004 Sep; 25(9):1671-9.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support